Medical male circumcision (MC) is a proven, one-time, cost-effective intervention for preventing new HIV infections and should be expanded, according to a new issue brief from the Center for Global Health Policy. Studies of MC in sub-Saharan Africa have already shown that MC can reduce a man’s chance of acquiring HIV through vaginal sex by up to 60 percent.
The Center’s report, “Medical Male Circumcision as HIV Prevention, Follow the Evidence: The case for aggressive scale up,” supports rapidly expanding MC services in countries with high HIV prevalence, low rates of MC, and a predominantly heterosexual epidemic. If fully implemented, MC can save millions of lives and significant resources, says the report, which summarizes the research in this area and outlines strategies for implementation.
“This monograph discusses best practices and highlights some of the recent successes in enhancing access to MC,” said Kenneth H. Mayer, MD, FIDSA, director of the Brown University AIDS Program and co-chair of the Center for Global Health Policy’s Scientific Advisory Committee. “MC is the first biomedical intervention with demonstrated efficacy for HIV prevention, but making it accessible to populations where the epidemic is expanding has proven to be challenging.”
The issue brief is available to download from the Center’s website. Additional print copies for distribution can be obtained from Center staff at no cost. Read more about the report and MC on the Center’s blog, Science Speaks.
Other recent blog updates include:
- Calling on President Barack Obama to remember the vital importance of global AIDS funding when finalizing his new budget request, 25 prominent leaders in the field of public health placed a half-page ad in Politico, a Capitol Hill newspaper, in December. The ad asked the president to significantly increase funding for the President’s Emergency Plan for AIDS Relief and the Global Fund to Fight AIDS, Tuberculosis and Malaria. See the related blog post for more about the ad).
- Zeke Emanuel, MD, PhD, has left the White House Office of Management & Budget and returned to his post at the National Institutes of Health (NIH), where he serves as head of the Department of Bioethics at the Clinical Center of the NIH. Kaiser Health News and Politico reported the move. Dr. Emanuel took part in several Science Speaks posts that generated discussion among global health experts, including an Oct. 2010 post on tuberculosis treatment that generated this response.
< Previous Article | Next Article >